Page last updated: 2024-08-24

goralatide and rxp 407

goralatide has been researched along with rxp 407 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cotton, J; Cuniasse, P; Dive, V; Vazeux, G1
Azizi, M; Corvol, P; Cotton, J; Dive, V; Ezan, E; Gonzales, MF; Junot, C; Michaud, A; Vassiliou, S; Vazeux, G; Yiotakis, A1
Beau, F; Cotton, J; Czarny, B; Dive, V; Georgiadis, D; Yiotakis, A1
Badaoui, S; Charrier, S; Corvol, P; Ezan, E; Giroux, S; Michaud, A; Sainteny, F; Vainchenker, W1

Other Studies

4 other study(ies) available for goralatide and rxp 407

ArticleYear
Potency and selectivity of RXP407 on human, rat, and mouse angiotensin-converting enzyme.
    Biochemical pharmacology, 2001, Apr-01, Volume: 61, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Interactions; Growth Inhibitors; Humans; Hydrolysis; Male; Mice; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Rats; Species Specificity; Testis

2001
RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:2

    Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hydrolysis; Indicators and Reagents; Lisinopril; Male; Mice; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Time Factors

2001
Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Circulation research, 2003, Jul-25, Volume: 93, Issue:2

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Bradykinin; Dose-Response Relationship, Drug; Drug Stability; Humans; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Peptidyl-Dipeptidase A; Phosphinic Acids; Substrate Specificity

2003
Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells.
    Blood, 2004, Aug-15, Volume: 104, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Cells; Bone Marrow; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Female; Hematopoiesis; Hematopoietic Stem Cells; Mice; Mice, Inbred C57BL; Oligopeptides; Peptidyl-Dipeptidase A; Perindopril; Phosphinic Acids; Radiation-Protective Agents; Survival Rate; Whole-Body Irradiation

2004
chemdatabank.com